Development of a robust method for establishing B cell lines using Epstein-Barr Virus.

Area of Science:

• Immunology
• Cell Biology
• Genetics

Background:

• B lymphoblastoid cell lines (B-LCLs) are crucial for various analyses due to their stable genomic structure.
• Establishing B-LCLs from Epstein-Barr virus (EBV)-infected B lymphocytes is typically highly efficient from fresh blood.
• Long-term storage or improper handling of peripheral blood mononuclear cells (PBMCs) significantly reduces B-LCL establishment efficiency.

Purpose of the Study:

• To enhance the success rate of establishing B-LCLs from challenging, irreplaceable PBMC samples stored for over 20 years.
• To identify critical parameters affecting B-LCL establishment from cryopreserved PBMCs sourced from remote indigenous populations.

Main Methods:

• Detailed examination of each step in the B-LCL establishment process from cryopreserved PBMCs.
• Systematic analysis of factors influencing EBV infection and cell culture initiation.
• Focus on PBMC plating density and EBV viral load (titer) as key variables.

Main Results:

• Identified PBMC plating density post-EBV infection as a critical factor for successful B-LCL establishment.
• Determined EBV titer to be another crucial parameter significantly impacting the success rate.
• These factors are particularly important when dealing with limited numbers of PBMCs or compromised cell viability.

Conclusions:

• Optimizing PBMC density and EBV titer are essential for improving B-LCL establishment from difficult-to-culture, cryopreserved samples.
• This research provides vital insights for researchers working with rare and valuable cell collections, minimizing sample wastage.
• The findings are particularly relevant for studies involving PBMCs from vulnerable or geographically isolated populations.